Does lymph node ratio have any prognostic significance in maximally cytoreduced node-positive low-grade serous ovarian carcinoma?
- 14 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Archiv für Gynäkologie
- Vol. 302 (1), 183-190
- https://doi.org/10.1007/s00404-020-05580-9
Abstract
Purpose To determine the prognostic impact of the lymph node ratio (LNR) in node-positive low-grade serous ovarian cancer (LGSOC). Methods We retrospectively reviewed women with LGSOC who had undergone maximal cytoreduction followed by standard chemotherapy in 11 centers from Turkey during a study period of 20 years. Sixty two women with node-positive LGSOC were identified. LNR was defined as the number of metastatic lymph nodes (LNs) divided by the number of total LNs removed. We grouped patients pursuant to the LNR as LNR ≤ 0.09 and LNR > 0.09. The prognostic value of LNR was investigated by employing the univariate log-rank test and multivariate Cox-regression model. Results With a median follow-up of 45 months, the 5-year progression-free survival (PFS) rates were 61.7% for women with LNR ≤ 0.09 and 32.0% for those with LNR > 0.09 (p = 0.046) whereas, the 5-year overall survival (OS) rates were 72.8% for LNR ≤ 0.09 and 54.7% for LNR > 0.09 (p = 0.043). On multivariate analyses, lymphovascular space invasion (LVSI) (Hazard Ratio [HR] 4.18, 95% confidence interval [CI] 1.88–9.27; p < 0.001), omental involvement (HR 3.48, 95% CI 1.36–8.84; p = 0.009) and LNR > 0.09 (HR 3.51, 95% CI 1.54–8.03; p = 0.003) were adverse prognostic factors for PFS. Additionally, LVSI (HR 6.56, 95% CI 2.33–18.41; p < 0.001), omental involvement (HR 6.34, 95% CI 1.86–21.57; p = 0.003) and LNR > 0.09 (HR 7.20, 95% CI 2.33–22.26; p = 0.001) were independent prognostic factors for decreased OS. Conclusion LNR > 0.09 seems to be an independent prognosticator for decreased survival outcomes in LGSOC patients who received maximal cytoreduction followed by standard adjuvant chemotherapy.Keywords
This publication has 41 references indexed in Scilit:
- Low-grade Serous Ovarian CarcinomaGeburtshilfe und Frauenheilkunde, 2018
- Ovarian carcinomas: at least five different diseases with distinct histological features and molecular geneticsHuman Pathology, 2018
- Does tumor grade influence the rate of lymph node metastasis in apparent early stage ovarian cancer?Archiv für Gynäkologie, 2018
- The Dualistic Model of Ovarian CarcinogenesisThe American Journal of Pathology, 2016
- Ovarian, fallopian tube and peritoneal cancer staging: Rationale and explanation of new FIGO staging 2013Best Practice & Research Clinical Obstetrics & Gynaecology, 2015
- Staging Classification for Cancer of the Ovary, Fallopian Tube, and PeritoneumObstetrics & Gynecology, 2015
- 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancerGynecologic Oncology, 2014
- Lymph node metastasis in stages I and II ovarian cancer: A reviewGynecologic Oncology, 2011
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker StudiesPLoS Medicine, 2008
- Grading Ovarian Serous Carcinoma Using a Two-Tier SystemThe American Journal of Surgical Pathology, 2004